Eudaimonia Partners’s Crocs CROX Stock Holding History

Eudaimonia Partners’s Portfolio CROX Stock Details CROX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-85	Closed	-$7K	–	567
2021 Q1	$7K	Buy	+85	New	+$6.48K	﹤0.01%	1242

Other funds holding CROX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Eudaimonia Partners's CROX Position: Q2 2021 in Review

Eudaimonia Partners sold out of Crocs (CROX) in Q2 2021, closing a stake of 85 shares — an estimated $7K sold.

Eudaimonia Partners first reported a position in CROX in Q1 2021 and held it in 1 quarter. The position peaked at $7K in Q1 2021. 348 funds tracked by Wall St. Rank hold CROX as of Q2 2021.

Eudaimonia Partners reported no remaining Crocs position as of Q2 2021 after selling out during the quarter.
Eudaimonia Partners sold 85 Crocs shares in Q2 2021, an estimated $7K.
Eudaimonia Partners first reported a position in Crocs in Q1 2021 and held it in 1 quarter.
Eudaimonia Partners's Crocs position peaked at $7K in Q1 2021.
348 funds tracked by Wall St. Rank held Crocs as of Q2 2021.

Based on Eudaimonia Partners's 13F filing for Q2 2021, filed 13 Aug 2021.